Biomedical subjects
Publications and source records attributed to M Hashimoto.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A study was made of diabetic retinopathy in acromegaly. 10 of 15 patients with acromegaly had diabetes mellitus, and 3 of the 10 showed diabetic retinopathy. 2 of them had a diabetic family history. 1 patient with a diabetic family history had retinopathy of state IIIa in Scott's classification, and the other 2 showed a few microaneurysms and/or punctate hemorrhages in the macula. Diabetes mellitus and diabetic retinopathy in acromegaly showed no correlation with the duration of acromegaly and diabetes mellitus, age, or growth hormone level. No diabetic cataract was found in the present series. It was concluded that diabetic retinopathy due to secondary diabetes mellitus is usually slight or moderate. Diabetes mellitus with severe retinopathy is probably primary diabetes due to a genetic defect, and secondary diabetes may be different in nature from the primary disease.
Explore the source record for details and available documents.
Macroautoradiographic studies on distribution of 14C-pipemidic acid in the guinea pig ear were performed after administration of the drug to provide its disposition for its application in the otolaryngological field. Petrosal bone, cochlea and auditory ossicles contained extremely low levels of 14C-pepemidic acid; blood, mucous tissues of tympanic cavity and tympanic membrane, low levels; tissues of external ear, moderate levels; and outer surface tissues of petrosal bone possibly including periosteum, significant levels. These otological tissue distributions of pipemidic acid suggest the effective applicability of the drug in the field.
Explore the source record for details and available documents.
Six-hydroxydopamine (6-OH-DA) was administered intraventricularly to 6-week-old and 5-month-old spontaneously hypertensive rats (SHR), and was administered into the spinal cord of 6-week-old SHR. Intraventricular administration of 6-OH-DA into 6-week-old SHR prevented the development of hypertension for at least 12 weeks; pressor response of the perfused hindquarters to noradrenaline was the same in 6-OH-DA-treated and vehicle-treated animals. Intraventricular administration of 6-OH-DA into 5-month-old SHR with established hypertension produced only a transient fall in blood pressure. Local injection of 6-OH-DA into the spinal cord produced a marked reduction only in spinal cord noradrenaline but did not affect the development of hypertension in SHR. These findings suggest that brain adrenergic neurons may participate in the development of hypertension in SHR but noradrenergic projections in the spinal cords are not essential for this process.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
6-Hydroxydopamine (6-OH-DA) was administered into the lateral brain ventricle of normal rats and of rats with renal hypertension produced by unilateral clipping of the renal artery, and was also administered into the spinal cord of normal rats. Intraventricular administration of 6-OH-DA prevented the development of renal hypertension in rats, but was ineffective in developed renal hypertension. The development of renal hypertension was not affected by pretreatment with intraspinal injection of 6-OH-DA, which produced a marked reduction only in spinal cord noradrenaline. These data suggest that brain adrenergic neurones may participate in the production of renal hypertension but the noradrenergic projections in the spinal cords are not essential for this process.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The clinical features of 57 autopsied cases of intrahepatic bile duct carcinoma including 28 cases of the peripheral type (cholangiocarcinoma in the narrow sense) and 29 cases of the hilar type are described in comparison with those of hepatocellular carcinoma, with a review of the literature on the clinicopathological aspects of intrahepatic bile duct carcinoma. As compared with hepatocellular carcinoma, the average age of the patients was older; the male predominance was not obvious, chronic parenchymal liver disease was infrequent in the past history, association of primary cirrhosis was seldom, cholestatic features were frequently the early signs and more pronounced during the course, the liver was enlarged to a lesser extent, ascites was less common, signs of portal hypertension were absent or minimal, and extrahepatic metastases were less frequent. In many respects, the hilar type resembled extrahepatic bile duct carcinoma, and the peripheral type was somewhat between it and hepatocellular carcinoma. Although the overall survival was not much different from that for hepatocellular carcinoma, early diagnosis is emphasized; this would make surgical management possible. Differential diagnosis from hepatocellular carcinoma may be possible in the majority with direct cholangiography, liver scan, celiac angiography, determination of alpha-fetoprotein and hepatitis B antigen, and blood chemistry such as SGOT, SLDH, serum bilirubin and alkaline phosphatase. Illustrative cases are given including one patient with a hilar carcinoma who survived for more than 2 years after transhepatic biliary drainage.
Serum enzyme activities were studied in 131 cases of hepatocellular carcinoma (HCC), 76 cases of metastatic liver carcinomas (MLC) and 234 cases of hepatic cirrhosis. SGOT was elevated above SGPT in most of the time in these patients, SGOT/SGPT was greater in HCC compared with other groups, and that this ratio increased during the preterminal period more markedly in patients with HCC because of the significant increase of SGOT in the face of relatively stable SGPT. Preterminal rises of alkaline phosphatase and LDH activities were more pronounced in MLC. Leucine aminopeptidase activity exhibited no characteristic feature of diagnostic value. Of the five enzymes, SGOT changes were more closely correlated with the growth of HCC; SGPT reflected more of the liver parenchymal damage while SGOT was probably accounted for in part by tumor-derived GOT. Other clinical and pathological implications are discussed.